Obesity Medicine

Latest News

Cost of Semaglutide, Tirzepatide Prohibitive Despite Significant Benefits
Cost of Semaglutide, Tirzepatide Prohibitive Despite Significant Benefits

March 14th 2025

A new economic evaluation estimates that semaglutide would need to drop its current price by 81.9% and tirzepatide by 30.5% to be cost effective.

CagriSema Phase 3 Update: Weight Loss of Nearly 16% Seen in REDEFINE 2 Trial /  image credit  Novo logo ©JHVE photo/stock.adobe.com
CagriSema Phase 3 Update: Weight Loss of Nearly 16% Seen in REDEFINE 2 Trial

March 11th 2025

Investigational Ketogenic Diet Pill BL-001 Shows Significant Weight Loss in Phase 1 Trial
Investigational Ketogenic Diet Pill BL-001 Shows Significant Weight Loss in Phase 1 Trial

March 5th 2025

Eli Lilly Expands Zepbound Access with New Vial Doses, Self-Pay Savings / Image credit: ©Douglas/AdobeStock
Eli Lilly Expands Zepbound Access with New Vial Doses, Self-Pay Savings

February 26th 2025

 Hims & Hers Super Bowl Ad for Semaglutide "Nothing Short of Reckless," Says Partnership for Safe Medicines / image credit Partnership for Safe Medicines
Hims & Hers Super Bowl Ad for Semaglutide "Nothing Short of Reckless," Says Partnership for Safe Medicines

February 7th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.